Skip to main content
. 2015 Mar 19;5:9330. doi: 10.1038/srep09330

Figure 5. p53 suppression leads to elevated NFκB binding to cxcr5 promoter in vivo.

Figure 5

(A) Map of cxcr5 promoter, predicted NFκB-binding sites and PCR products amplified in ChIP assay. (B) Suppression of p53 in MCF-7 cells leads to elevated p65/RelA crosslinking to the amplicons containing NFκB consensus sites 2 and 3.